Stockreport

AVEO Oncology Announces Regulatory Update for Tivozanib in Renal Cell Carcinoma

AVEO Pharmaceuticals, Inc.  (AVEO) 
Last aveo pharmaceuticals, inc. earnings: 3/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.aveooncology.com
PDF - NDA Filing Planned for 1Q20 for Relapsed/Refractory RCC –- Company Plans Final OS Analysis in 2Q20 - CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) [Read more]